Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ATAI Life Sciences (ATAI)
NASDAQ:ATAI
Holding ATAI?
Track your performance easily
ATAI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.03 - $2.85
Previous Close$1.59
Volume842.71K
Average Volume (3M)1.07M
Market Cap
$281.17M
Enterprise Value$282.08M
Total Cash (Recent Filing)$29.96M
Total Debt (Recent Filing)$21.14M
Price to Earnings (P/E)―
Beta2.23
Next Earnings
Mar 27, 2025EPS Estimate
-$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.80
Shares Outstanding167,802,396
10 Day Avg. Volume3,621,614
30 Day Avg. Volume1,066,685
Standard Deviation0.17
R-Squared0.05
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)1.83
Price to Sales (P/S)877.03
Price to Cash Flow (P/CF)-3.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue852.19
Enterprise Value/Gross Profit898.33
Enterprise Value/Ebitda-2.95
Forecast
1Y Price Target
$10.67Price Target Upside592.86% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
ATAI Life Sciences News
PremiumCompany Announcements
Atai Life Sciences Advances Psychedelic Treatments in Q3 2024
PremiumCompany Announcements
ATAI Life Sciences Reports Q3 Results and New TrialsOwnership Overview
33.60% Insiders
0.62% Mutual Funds
1.26% Other Institutional Investors
63.28% Public Companies and
Individual Investors
ATAI FAQ
What was ATAI Life Sciences’s price range in the past 12 months?
ATAI Life Sciences lowest stock price was $1.02 and its highest was $2.85 in the past 12 months.
What is ATAI Life Sciences’s market cap?
Currently, no data Available
When is ATAI Life Sciences’s upcoming earnings report date?
ATAI Life Sciences’s upcoming earnings report date is Mar 27, 2025 which is in 126 days.
How were ATAI Life Sciences’s earnings last quarter?
ATAI Life Sciences released its earnings results on Nov 13, 2024. The company reported -$0.16 earnings per share for the quarter, the consensus estimate of -$0.16 by $0.
Is ATAI Life Sciences overvalued?
According to Wall Street analysts ATAI Life Sciences’s price is currently Undervalued.
Does ATAI Life Sciences pay dividends?
ATAI Life Sciences does not currently pay dividends.
What is ATAI Life Sciences’s EPS estimate?
ATAI Life Sciences’s EPS estimate is -$0.14.
How many shares outstanding does ATAI Life Sciences have?
ATAI Life Sciences has 167,802,400 shares outstanding.
What happened to ATAI Life Sciences’s price movement after its last earnings report?
ATAI Life Sciences reported an EPS of -$0.16 in its last earnings report, expectations of -$0.16. Following the earnings report the stock price went down -7.534%.
Which hedge fund is a major shareholder of ATAI Life Sciences?
Among the largest hedge funds holding ATAI Life Sciences’s share is Woodline Partners LP. It holds ATAI Life Sciences’s shares valued at 621K.
---
ATAI Life Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.67 (592.86% Upside)
$10.67 (592.86% Upside)
Blogger Sentiment
Bullish
ATAI Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 535.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▲ 3.3%
Last 30 Days ▲ 3.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
41.96%
12-Months-Change
Fundamentals
Return on Equity
-62.43%
Trailing 12-Months
Asset Growth
-35.92%
Trailing 12-Months
Company Description
ATAI Life Sciences
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine.
---
ATAI Stock 12 Month Forecast
Average Price Target
$10.67
▲(592.86% Upside)
Technical Analysis
Best Analysts Covering ATAI
1 Year
1 Year Success Rate
6/23 ratings generated profit
1 Year Average Return
-26.20%
reiterated a buy rating 3 months ago
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 26.09% of your transactions generating a profit, with an average return of -26.20% per trade.
---